NASDAQ:DMRA | Insider Transactions — Page 3 | Damora Therapeutics, Inc.

DMRA Insider Transactions — Page 3

215 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–215; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Winslow GarrettGeneral Counsel2021-06-23Purchase2,000.0$4.8
Novo Holdings A/STenPercentOwner2020-11-02Purchase333,333.0$15.0
ORBIMED ADVISORS LLCDirector,TenPercentOwner2020-11-02Purchase209,500.0$15.0
OrbiMed Israel GP II, L.P.Director,TenPercentOwner2020-11-02Purchase209,500.0$15.0
OrbiMed Advisors Israel II LtdDirector,TenPercentOwner2020-11-02Purchase209,500.0$15.0
OrbiMed Capital GP VII LLCDirector,TenPercentOwner2020-11-02Purchase209,500.0$15.0
OrbiMed Genesis GP LLCDirector,TenPercentOwner2020-11-02Purchase209,500.0$15.0
ORBIMED ADVISORS LLCDirector,TenPercentOwner2020-11-02Purchase523,833.0$15.0
OrbiMed Israel GP II, L.P.Director,TenPercentOwner2020-11-02Purchase523,833.0$15.0
OrbiMed Advisors Israel II LtdDirector,TenPercentOwner2020-11-02Purchase523,833.0$15.0
OrbiMed Capital GP VII LLCDirector,TenPercentOwner2020-11-02Purchase523,833.0$15.0
OrbiMed Genesis GP LLCDirector,TenPercentOwner2020-11-02Purchase523,833.0$15.0
Khuong Chau QuangDirector,TenPercentOwner2020-11-02Purchase209,500.0$15.0
Khuong Chau QuangDirector,TenPercentOwner2020-11-02Purchase523,833.0$15.0
Christgau StephanDirector2020-11-02Purchase66,666.0$15.0